Carbonic anhydrase inhibitor 12
Carbonic anhydrase inhibitor 12 is a potent CA II inhibitor, also has inhibitory activity in CA I (Kis of 1.72 and 271 nM in CA II and CA I, respectively). Carbonic anhydrase inhibitor 12 has potent anticancer activity against different cancer cell lines.
For research use only. We do not sell to patients.
- CAS No.: 2883451-38-3
- Formula: C27H22BrN5O5S2
- Molecular Weight:640.53
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
CA Ⅱ |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
16.5 μM
Compound: 14h
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
|
[PMID: 34847409] |
| COLO 205 | IC50 |
13.3 μM
Compound: 14h
|
Antiproliferative activity against human COLA 205 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
Antiproliferative activity against human COLA 205 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
|
[PMID: 34847409] |
| HCT-116 | IC50 |
2.5 μM
Compound: 14h
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
|
[PMID: 34847409] |
| HT-29 | IC50 |
4.3 μM
Compound: 14h
|
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
|
[PMID: 34847409] |
| MCF7 | IC50 |
2.5 μM
Compound: 14h
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
|
[PMID: 34847409] |
| MDA-MB-231 | IC50 |
2.4 μM
Compound: 14h
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
|
[PMID: 34847409] |
| NCI/ADR-RES | IC50 |
33.7 μM
Compound: 14h
|
Antiproliferative activity against human NCI-ADR-RES cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
Antiproliferative activity against human NCI-ADR-RES cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
|
[PMID: 34847409] |
| SK-OV-3 | IC50 |
29.9 μM
Compound: 14h
|
Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
|
[PMID: 34847409] |
| SW-620 | IC50 |
4.5 μM
Compound: 14h
|
Antiproliferative activity against human SW-620 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
Antiproliferative activity against human SW-620 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
|
[PMID: 34847409] |
| T47D | IC50 |
2.4 μM
Compound: 14h
|
Antiproliferative activity against human T47D cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
Antiproliferative activity against human T47D cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
|
[PMID: 34847409] |
Carbonic anhydrase inhibitor 12 (Compound 14h) (10 μM; 48 hours; single) has great influence on the specificity and the inhibitory potency against the different cancer cell lines[1].
Carbonic anhydrase inhibitor 12 (2.4 μM in MCF-7 and 2.5 μM MDA-MB-231; 48 hours) can arrest the cell cycle of MCF-7 and MDA-MB-231 cells at the G2/M phase[1].
Carbonic anhydrase inhibitor 12 (2.4 μM in MCF-7 and 2.5 μM MDA-MB-231; 48 hours) demonstrates an increase in the early apoptotic and late apoptotic phase in comparison to the control untreated cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MCF-7, T47D, MDA-MB-231, COLO 205, HCT-116, HT29, SW-620, A549, SK-OV-3 and NCI-ADR-RES[1]
-
Concentration:10 μM
-
Incubation Time:48 hours
-
Result:Showed a mean growth inhibitory activity of 55.12% and a broad range of antiproliferative activity against most of the tested cancer cell lines.
-
Cell Line:MCF-7 and MDA-MB-231[1]
-
Concentration:2.4 μM in MCF-7, 2.5 μM MDA-MB-231
-
Incubation Time:48 hours
-
Result:Arrested the cell cycle of MCF-7 and MDA-MB-231 cells at the G2/M phase.
-
Cell Line:MCF-7 and MDA-MB-231[1]
-
Concentration:2.4 μM in MCF-7, 2.5 μM MDA-MB-231
-
Incubation Time:48 hours
-
Result:Demonstrated an increase in the early apoptotic and late apoptotic phase in comparison to the control untreated cells.
Chemical Information
-
CAS No. 2883451-38-3
-
Molecular Weight 640.53
-
Formula C27H22BrN5O5S2
-
SMILES
COC1=CC=C(C(C2=NC(SCC(C3=CC=C(C=C3)Br)=O)=NC(NC4=CC=C(C=C4)S(N)(=O)=O)=C2C#N)=C1)OC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)